newsfilter
← Latest News
GlobeNewswire·

Reneo Pharmaceuticals Reports Third Quarter 2021 Financial Results

IRVINE, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic, mitochondrial diseases,